glp-1 thyroid cancer RAs and Cancer: What Does the Evidence Say? | Paramesh Shamanna posted on the topic Thyroid and glp1 | TikTok

Although compounding pharmacies must still follow strict safety and quality guidelines, they dont submit their products for FDA review, and they dont have to prove clinical efficacy

A Dual-Action Treatment Tirzepatide is known as a dual agonist because it works on two hormone pathways in the body: GLP-1 and GIP

The connection remains investigational, and any effects on alcohol consumption should be considered preliminary findings requiring rigorous clinical validation

No, compounded formulations are not FDA-approved products

GZGI Investigators

69 Potential mechanisms include decreased intestinal lipid production, reduced intestinal triglyceride absorption due to lowered secretion of apoB48-containing chylomicrons, smaller postprandial triglyceride secretion and effects on the expression of genes involved in lipid metabolism